Year 2017 / Volume 109 / Number 3
Original
The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire

196-201

DOI: 10.17235/reed.2017.4621/2016

Edel Berroa de la Rosa, Natalia Mora Cuadrado, Luis Fernández Salazar,

Abstract
Background and objectives: Concerns impact the quality of life for patients with inflammatory bowel disease (IBD). We attempted to identify the concerns of IBD patients in our practice, and to assess the applicability of the Rating Form of IBD Patients Concerns (RFIPC) questionnaire to Spanish patients. Patients and methods: One hundred and thirty-one patients seen in our practice filled out the Spanish version of RFIPC. The questionnaire’s reliability, validity, and discriminating power were analyzed. Results: The total score was 46.93, with a standard deviation (SD) of 21.475. Primary concerns included: “having an ostomy bag”, “effects of medication”, “developing cancer”, “energy level”, and “uncertain nature of disease”. Female patients scored higher on total RFIPC and on most items. Cronbach’s alpha was 0.924. A good correlation was seen between two consecutive answers for 37 patients; the Spearman’s coefficient was 0.842 (p < 0.001), and the intraclass correlation coefficient (ICC) was 0.775 (p < 0.001). Correlation was also found between RFIPC and both the IBDQ-32 emotional domain (0.413, p < 0.001) and anxiety scale (0.543, p < 0.001). Conclusions: The RFIPC questionnaire may be administered to Spanish patients.
Share Button
New comment
Comments
No comments for this article
References
1. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989 Mar;96(3):804-10. PubMed PMID: 2644154. Epub 1989/03/01. eng.
DOI: 10.1016/0016-5085(89)90905-0
2. Vogelaar L, Spijker AV, van der Woude CJ. The impact of biologics on health-related quality of life in patients with inflammatory bowel disease. Clinical and experimental gastroenterology. 2009;2:101-9. PubMed PMID: 21694833. Pubmed Central PMCID: PMC3108643. Epub 2009/01/01. eng.
DOI: 10.2147/CEG.S4512
3. Hjortswang H, Almer S, Strom M. The network: a strategy to describe the relationship between quality of life and disease activity. The case of inflammatory bowel disease. European journal of gastroenterology & hepatology. 1999 Oct;11(10):1099-104. PubMed PMID: 10524638. Epub 1999/10/19. eng.
DOI: 10.1097/00042737-199910000-00005
4. Hjortswang H, Jarnerot G, Curman B, Sandberg-Gertzen H, Tysk C, Blomberg B, et al. The Short Health Scale: a valid measure of subjective health in ulcerative colitis. Scandinavian journal of gastroenterology. 2006 Oct;41(10):1196-203. PubMed PMID: 16990205. Epub 2006/09/23. eng.
DOI: 10.1080/00365520600610618
5. Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Digestive diseases and sciences. 1989 Sep;34(9):1379-86. PubMed PMID: 2766905. Epub 1989/09/01. eng.
DOI: 10.1007/BF01538073
6. Drossman DA, Leserman J, Li ZM, Mitchell CM, Zagami EA, Patrick DL. The rating form of IBD patient concerns: a new measure of health status. Psychosomatic medicine. 1991 Nov-Dec;53(6):701-12. PubMed PMID: 1758953. Epub 1991/11/01. eng.
DOI: 10.1097/00006842-199111000-00010
7. Moser G, Tillinger W, Sachs G, Genser D, Maier-Dobersberger T, Spiess K, et al. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. European journal of gastroenterology & hepatology. 1995 Sep;7(9):853-8. PubMed PMID: 8574717. Epub 1995/09/01. eng.
8. Colombel JF, Yazdanpanah Y, Laurent F, Houcke P, Delas N, Marquis P. [Quality of life in chronic inflammatory bowel diseases. Validation of a questionnaire and first French data]. Gastroenterol Clin Biol. 1996;20(12):1071-7. PubMed PMID: 9033853. Epub 1996/01/01. Qualite de vie dans les maladies inflammatoires chroniques de l'intestin. Validation d'un questionnaire et premieres donnees francaises. fre.
9. Jelsness-Jorgensen LP, Moum B, Bernklev T. Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year. Gastroenterology research and practice. 2011;2011:492034. PubMed PMID: 21912537. Pubmed Central PMCID: PMC3168269. Epub 2011/09/14. eng.
10. Lesage AC, Hagege H, Tucat G, Gendre JP. Results of a national survey on quality of life in inflammatory bowel diseases. Clin Res Hepatol Gastroenterol. 2011 Feb;35(2):117-24. PubMed PMID: 21036501. Epub 2010/11/03. eng.
DOI: 10.1016/j.gcb.2009.08.015
11. Mussell M, Bocker U, Nagel N, Singer MV. Predictors of disease-related concerns and other aspects of health-related quality of life in outpatients with inflammatory bowel disease. European journal of gastroenterology & hepatology. 2004 Nov;16(12):1273-80. PubMed PMID: 15618832. Epub 2004/12/25. eng.
DOI: 10.1097/00042737-200412000-00007
12. Hjortswang H, Strom M, Almer S. Health-related quality of life in Swedish patients with ulcerative colitis. The American journal of gastroenterology. 1998 Nov;93(11):2203-11. PubMed PMID: 9820397. Epub 1998/11/20. eng.
DOI: 10.1111/j.1572-0241.1998.00537.x
13. Stjernman H, Tysk C, Almer S, Strom M, Hjortswang H. Worries and concerns in a large unselected cohort of patients with Crohn's disease. Scandinavian journal of gastroenterology. 2010 Jun;45(6):696-706. PubMed PMID: 20334474. Epub 2010/03/26. eng.
DOI: 10.3109/00365521003734141
14. Maunder R, Toner B, de Rooy E, Moskovitz D. Influence of sex and disease on illness-related concerns in inflammatory bowel disease. Can J Gastroenterol. 1999 Nov;13(9):728-32. PubMed PMID: 10633825. Epub 2000/01/14. eng.
DOI: 10.1155/1999/701645
15. Levenstein S, Li Z, Almer S, Barbosa A, Marquis P, Moser G, et al. Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. The American journal of gastroenterology. 2001 Jun;96(6):1822-30. PubMed PMID: 11419836. Epub 2001/06/23. eng.
DOI: 10.1111/j.1572-0241.2001.03878.x
16. Miehsler W, Weichselberger M, Offerlbauer-Ernst A, Dejaco C, Reinisch W, Vogelsang H, et al. Assessing the demand for psychological care in chronic diseases: development and validation of a questionnaire based on the example of inflammatory bowel disease. Inflammatory bowel diseases. 2004 Sep;10(5):637-45. PubMed PMID: 15472527. Epub 2004/10/09. eng.
DOI: 10.1097/00054725-200409000-00021
17. Fundación Roma. http://theromefoundation.org.
18. Masachs M, Casellas F, Malagelada JR. [Spanish translation, adaptation, and validation of the 32-item questionnaire on quality of life for inflammatory bowel disease(IBDQ-32)]. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2007 Sep;99(9):511-9. PubMed PMID: 18052646. Epub 2007/12/07. Traduccion, adaptacion y validacion al espanol del cuestionario de calidad de vida de 32 items (IBDQ-32) de la enfermedad inflamatoria intestinal. spa.
DOI: 10.4321/S1130-01082007000900006
19. Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. General hospital psychiatry. 2003 Jul-Aug;25(4):277-83. PubMed PMID: 12850660. Epub 2003/07/10. eng.
DOI: 10.1016/S0163-8343(03)00043-4
20. de Rooy EC, Toner BB, Maunder RG, Greenberg GR, Baron D, Steinhart AH, et al. Concerns of patients with inflammatory bowel disease: results from a clinical population. The American journal of gastroenterology. 2001 Jun;96(6):1816-21. PubMed PMID: 11419835. Epub 2001/06/23. eng.
DOI: 10.1111/j.1572-0241.2001.03877.x
21. Restall GJ, Simms AM, Walker JR, Graff LA, Sexton KA, Rogala L, et al. Understanding Work Experiences of People with Inflammatory Bowel Disease. Inflammatory bowel diseases. 2016 Jul;22(7):1688-97. PubMed PMID: 27271487. Epub 2016/06/09. eng.
DOI: 10.1097/MIB.0000000000000826
22. Keeton RL, Mikocka-Walus A, Andrews JM. Concerns and worries in people living with inflammatory bowel disease (IBD): A mixed methods study. Journal of psychosomatic research. 2015 Jun;78(6):573-8. PubMed PMID: 25543858. Epub 2014/12/30. eng.
DOI: 10.1016/j.jpsychores.2014.12.004
23. Casellas F, Lopez-Vivancos J, Casado A, Malagelada JR. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res. 2002 Dec;11(8):775-81. PubMed PMID: 12482161. Epub 2002/12/17. eng.
24. Hauser G, Tkalcic M, Stimac D, Milic S, Sincic BM. Gender related differences in quality of life and affective status in patients with inflammatory bowel disease. Collegium antropologicum. 2011 Sep;35 Suppl 2:203-7. PubMed PMID: 22220436. Epub 2012/01/10. eng.
25. Lesuis N, Befrits R, Nyberg F, van Vollenhoven RF. Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study. BMC medicine. 2012;10:82. PubMed PMID: 22853635. Pubmed Central PMCID: PMC3414735. Epub 2012/08/03. eng.
DOI: 10.1186/1741-7015-10-82
26. Blumenstein I, Herrmann E, Filmann N, Zosel C, Tacke W, Bock H, et al. Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study. Journal of Crohn's & colitis. 2011 Jun;5(3):203-10. PubMed PMID: 21575882. Epub 2011/05/18. eng.
DOI: 10.1016/j.crohns.2010.12.012
27. Casellas F, Rodrigo L, Molina-Infante J, Vivas S, Lucendo AJ, Rosinach M, et al. Transcultural adaptation and validation of the Celiac Disease Quality of Life (CD-QOL) Survey, a specific questionnaire to measure quality of life in patients with celiac disease. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2013 Nov-Dec;105(10):585-93. PubMed PMID: 24641455. Epub 2014/03/20. eng.
DOI: 10.4321/S1130-01082013001000003
28. Lucendo AJ, Sanchez-Cazalilla M, Molina-Infante J, Perez-Martinez I, Tenias JM, Barrio J, et al. Transcultural adaptation and validation of the "Adult Eosinophilic Esophagitis Quality of Life Questionnaire" into Spanish. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2014 Jun;106(6):386-94. PubMed PMID: 25361449. Epub 2014/11/02. eng.
29. Bergquist U, Babic A. Aspects of certainty in patient classification using a health-related quality-of-life instrument in inflammatory bowel disease. Proc AMIA Symp. 1999:202-6. PubMed PMID: 10566349. Pubmed Central PMCID: PMC2232609. Epub 1999/11/24. eng.
30. Hjortswang H, Strom M, Almeida RT, Almer S. Evaluation of the RFIPC, a disease-specific health-related quality of life questionnaire, in Swedish patients with ulcerative colitis. Scandinavian journal of gastroenterology. 1997 Dec;32(12):1235-40. PubMed PMID: 9438322. Epub 1998/01/23. eng.
DOI: 10.3109/00365529709028153
31. Stjernman H, Granno C, Jarnerot G, Ockander L, Tysk C, Blomberg B, et al. Short health scale: a valid, reliable, and responsive instrument for subjective health assessment in Crohn's disease. Inflammatory bowel diseases. 2008 Jan;14(1):47-52. PubMed PMID: 17828783. Epub 2007/09/11. eng.
DOI: 10.1002/ibd.20255
32. Blondel-Kucharski F, Chircop C, Marquis P, Cortot A, Baron F, Gendre JP, et al. Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. The American journal of gastroenterology. 2001 Oct;96(10):2915-20. PubMed PMID: 11693326. Epub 2001/11/06. eng.
DOI: 10.1111/j.1572-0241.2001.04681.x
Related articles

Letter

Intestinal ultrasound and its role in the acute setting: stenosing Crohn’s disease and acute bowel obstruction due to foreign body ingestion (dental post and crown)

DOI: 10.17235/reed.2024.10677/2024

Original

Ultrasound transmural healing correlates with higher adalimumab drug concentration in Crohn’s disease only in the short-term

DOI: 10.17235/reed.2024.10489/2024

Letter

Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) complicated with intestinal obstruction and perforation

DOI: 10.17235/reed.2024.10407/2024

Original

Validation and adaptation to Spanish of the quality-of-life questionnaire in patients with hemorrhoidal disease and anal fissure (HEMO-FISS-CdV)

DOI: 10.17235/reed.2024.10308/2024

Letter

A novel nomogram for predicting endoscopic remission in refractory Crohn’s disease with ustekinumab administration

DOI: 10.17235/reed.2024.10212/2023

Letter

An Epstein-Barr virus-positive mucocutaneous ulcer in a patient with ulcerative colitis: a recently described entity to take into account

DOI: 10.17235/reed.2024.10168/2023

Letter

Treatment with hyperbaric oxygen in a Crohn’s disease patient

DOI: 10.17235/reed.2024.10166/2023

Letter

Long-term remission achieved in a rare case of pyoderma gangrenosum and ulcerative colitis with surgery and postoperative infliximab

DOI: 10.17235/reed.2024.10144/2023

Letter

Comments on: “Perianal Crohn’s disease: clinical implications, prognosis and use of resources”

DOI: 10.17235/reed.2023.10013/2023

Letter

Ulcerative colitis induced by obinutuzumab in a patient treated for a follicular lymphoma

DOI: 10.17235/reed.2023.10009/2023

Letter

Coincidental oral lesions in Crohn’s disease

DOI: 10.17235/reed.2023.9992/2023

Letter

Effectiveness of 4 L, 2 L, and 1 L polyethylene glycol (PEG) bowel preparation for colonoscopy in patients with ulcerative colitis: a retrospective study

DOI: 10.17235/reed.2023.9979/2023

Original

Psychological disorders and coping strategies in patients with inflammatory bowel disease. Their impact on health-related quality of life

DOI: 10.17235/reed.2023.9935/2023

Letter

Is cervical dysplasia a major concern in females with inflammatory bowel disease? A Spanish retrospective study

DOI: 10.17235/reed.2023.9890/2023

Letter

Tofacitinib-induced eosinophilia

DOI: 10.17235/reed.2023.9831/2023

Original

Ulcerative colitis overall disease severity index predicts colectomy: a prospective cohort study

DOI: 10.17235/reed.2023.9754/2023

Letter

Infliximab-induced psoriasis in an ulcerative colitis patient successfully treated with guselkumab

DOI: 10.17235/reed.2023.9745/2023

Original

Development and validation of a nomogram to predict non-response to 5-aminosalicylic acid in patients with ulcerative colitis

DOI: 10.17235/reed.2023.9703/2023

Original

FiLaC® procedure for highly selected anal fistula patients: indications, safety and efficacy from an observational study at a tertiary referral center

DOI: 10.17235/reed.2023.9644/2023

Letter

Extensive involvement of indolent T-cell lymphoma in a patient with ulcerative colitis

DOI: 10.17235/reed.2023.9623/2023

Letter

Iatrogenic rectal perforation due to application of topical treatment in a patient with ulcerative colitis: a rare complication

DOI: 10.17235/reed.2023.9599/2023

Original

Long-term clinical outcomes after the discontinuation of anti-TNF agents in patients with inflammatory bowel disease: a meta-analysis

DOI: 10.17235/reed.2023.9537/2023

Letter

Severe outbreak of ulcerative colitis and cerebral neoplasia. Difficult management in COVID time

DOI: 10.17235/reed.2023.9527/2023

Letter

Duodenal stenosis surgical treatment in Crohn’s disease

DOI: 10.17235/reed.2023.9521/2023

Letter

Henoch-Schönlein purpura masquerading as Crohn’s disease flare

DOI: 10.17235/reed.2022.9414/2022

Original

Effectiveness and safety of ustekinumab dose escalation in Crohn’s disease: a multicenter observational study

DOI: 10.17235/reed.2023.9402/2022

Letter

Prediagnosis of soft tissue infection that was finally diagnosed as pyoderma gangrenosum of ulcerative colitis

DOI: 10.17235/reed.2022.9332/2022

Letter

Perianal Paget’s disease

DOI: 10.17235/reed.2022.9304/2022

Letter

Use of teduglutide for short bowel syndrome and Crohn’s disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy

DOI: 10.17235/reed.2022.9194/2022

Letter

A rare case of ulcerative colitis following Bacillus Calmette-Guérin therapy

DOI: 10.17235/reed.2022.9191/2022

Letter

Ulcerative colitis complicated by autoimmune hepatitis-primary biliary cholangitis-primary sclerosing cholangitis overlap syndrome

DOI: 10.17235/reed.2022.9183/2022

Letter

Chinese dragon sign of ulcerative colitis

DOI: 10.17235/reed.2022.9154/2022

Letter

Pyoderma gangrenosum in ulcerative colitis - An exuberant and painful complication

DOI: 10.17235/reed.2022.9120/2022

Letter

Ulcerative colitis exacerbated by strongyloidiasis

DOI: 10.17235/reed.2022.9044/2022

Letter

A diagnostic challenge: chronic cutaneous ulcers as an isolated clinical finding in metastatic Crohn’s disease

DOI: 10.17235/reed.2022.8995/2022

Digestive Diseases Image

Intestinal and perianal tuberculosis: an uncommon clinical presentation and challenging diagnosis

DOI: 10.17235/reed.2022.8988/2022

Letter

Dual biologic therapy for severe ulcerative colitis, concomitant extraintestinal manifestations and an orbital osteoma: a successful treatment

DOI: 10.17235/reed.2022.8964/2022

Digestive Diseases Image

Peristomal cutaneous Crohn's disease by contiguity

DOI: 10.17235/reed.2022.8909/2022

Letter

A rare case of an intestinal ulcer: AIDS and amebic colitis in a homosexual man with ulcerative colitis

DOI: 10.17235/reed.2022.8903/2022

Letter

One appendix too many: a severe IBD-U case in remission after appendectomy

DOI: 10.17235/reed.2022.8809/2022

Original

Health-related quality of life decline in clinically stable inflammatory bowel disease patients during the COVID-19 outbreak

DOI: 10.17235/reed.2022.8668/2022

Review

Clinical settings with tofacitinib in ulcerative colitis

DOI: 10.17235/reed.2022.8660/2022

Letter

Mesalazine induced interstitial pneumonitis in the COVID era

DOI: 10.17235/reed.2022.8635/2021

Original

Efficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia

DOI: 10.17235/reed.2022.8380/2021

Letter

Anal neoplasia and perianal Crohn’s disease: myth or reality?

DOI: 10.17235/reed.2021.8317/2021

Letter

Ileal endometriosis in a patient with Crohn’s disease: a diagnostic challenge

DOI: 10.17235/reed.2021.8187/2021

Original

Impact of the COVID-19 lockdown on liver transplant recipients. A single center observational study

DOI: 10.17235/reed.2021.8173/2021

Review

Adherence improvement in patients with ulcerative colitis: a multidisciplinary consensus document

DOI: 10.17235/reed.2021.8130/2021

Original

Incidence of inflammatory bowel disease and phenotype at diagnosis in 2011: results of the Epi-IBD 2011 study in the Vigo area

DOI: 10.17235/reed.2021.8003/2021

Original

Perianal Crohn’s disease: clinical implications, prognosis and use of resources

DOI: 10.17235/reed.2021.7918/2021

Letter

Influence of the onset of the SARS-CoV-2 pandemic on the diagnosis and treatment of ulcerative colitis

DOI: 10.17235/reed.2021.7768/2020

Original

Usefulness of peripheral blood monocyte count to predict relapse in patients with inflammatory bowel disease: a prospective longitudinal cohort study

DOI: 10.17235/reed.2021.7683/2020

Original

Thiopurine adherence: a high prevalence with low impact on UC outcomes

DOI: 10.17235/reed.2021.7630/2020

Letter

A case of severe diverticulosis in a patient with ulcerative colitis

DOI: 10.17235/reed.2020.7529/2020

Review

The use of contrast-enhanced ultrasound for chronic inflammatory bowel disease

DOI: 10.17235/reed.2020.7499/2020

Original

Views of patients with inflammatory bowel disease during the COVID-19 pandemic: ACCU survey results

DOI: 10.17235/reed.2020.7472/2020

Original

Prognostic value of ultrasound activity and parietal healing in patients with Crohn’s disease

DOI: 10.17235/reed.2020.7347/2020

Original

Adherence to a gluten-free diet and quality of life in Chilean celiac patients

DOI: 10.17235/reed.2020.7293/2020

Letter

Effectiveness and safety of switching to adalimumab biosimilar ABP 501 in Crohn’s disease

DOI: 10.17235/reed.2020.7232/2020

Original

Preliminary experience of maintenance treatment with intravenous ustekinumab as a rescue treatment for loss of response to subcutaneous doses

DOI: 10.17235/reed.2020.7230/2020

Original

Ustekinumab treatment for toxic megacolon in severe colonic Crohn’s disease

DOI: 10.17235/reed.2020.7228/2020

Original

Prevalence and factors associated with poor sleep quality in inflammatory bowel disease outpatients

DOI: 10.17235/reed.2020.7202/2020

Letter

Author´s answer to: “Effect of adacolumn® in ulcerative colitis with COVID-19”

DOI: 10.17235/reed.2020.7188/2020

Original

Rectal advancement flaps for the treatment of transphincteric perianal fistulas: a three-dimensional endoanal ultrasound and quality of life assessment

DOI: 10.17235/reed.2020.7187/2020

Letter

The effect of Adacolumn® on ulcerative colitis with COVID-19

DOI: 10.17235/reed.2020.7156/2020

Original

Association between ustekinumab trough concentrations and biochemical outcomes in patients with Crohn’s disease. A real life study

DOI: 10.17235/reed.2020.7124/2020

Review

Vitamin D and inflammatory bowel disease: what do we know so far?

DOI: 10.17235/reed.2020.7061/2020

Original

Glasgow prognostic score is a predictive index for postoperative infectious complications after total proctocolectomy in ulcerative colitis patients

DOI: 10.17235/reed.2020.7047/2020

Letter

Sweet syndrome in severe ulcerative flare

DOI: 10.17235/reed.2020.6995/2020

Review

The diagnostic and predictive value of fecal calprotectin and capsule endoscopy for small-bowel Crohn’s disease: a systematic review and meta-analysis

DOI: 10.17235/reed.2020.6996/2020

Original

Normalization of long-term quality of life in Crohn’s disease patients receiving ustekinumab

DOI: 10.17235/reed.2020.6941/2020

Original

Autoimmune sequential overlap syndrome (autoimmune hepatitis/primary sclerosing cholangitis) and inflammatory bowel disease: three clinical cases

DOI: 10.17235/reed.2020.6938/2020

Letter

Retrograde enteroclysis by double balloon enteroscopy in a patient with blunt abdominal trauma: small bowel stricture, intraluminal vascular lesion and Crohn’s disease

DOI: 10.17235/reed.2020.6891/2020

Original

Treatment of abdominal fistulas in Crohn’s disease and monitoring with abdominal ultrasonography

DOI: 10.17235/reed.2020.6884/2020

Original

Is endoscopic treatment of small bowel strictures effective and safe in patients with Crohn’s disease?

DOI: 10.17235/reed.2020.6852/2019

Original

Meta-analysis of protein intake on the effect of Crohn’s disease and ulcerative colitis

DOI: 10.17235/reed.2020.6851/2019

Original

Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn’s disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain

DOI: 10.17235/reed.2020.6847/2019

Original

Index of the Mayo Endoscopy and Ulcerative Colitis Endoscopy Index of Severity: are they equally valid?

DOI: 10.17235/reed.2020.6832/2019

Letter

Vedolizumab-associated psoriasis: until where does gut selectivity go?

DOI: 10.17235/reed.2020.6817/2019

Original

Is the degree of i2a recurrence in Crohn’s disease secondary to ischemic phenomena?

DOI: 10.17235/reed.2020.6790/2019

Original

Predictive factors of clinical response to treatment with anti-TNF agents in ulcerative colitis: what have we learned from our patients?

DOI: 10.17235/reed.2020.6688/2019

Original

Association between autoimmune pancreatitis and ulcerative colitis: a report of 12 patients

DOI: 10.17235/reed.2020.6677/2019

Letter

Intra-abdominal desmoid tumor and chronic inflammatory bowel disease. An uncommon scenario

DOI: 10.17235/reed.2020.6648/2019

Letter

Crohn’s disease in patients treated with etanercept

DOI: 10.17235/reed.2019.6554/2019

Original

Diet as an environmental trigger in inflammatory bowel disease: a retrospective comparative study in two European cohorts

DOI: 10.17235/reed.2020.6552/2019

Original

Lewis score: a useful tool for diagnosis and prognosis in Crohn’s disease

DOI: 10.17235/reed.2020.6434/2019

Original

Evolution of perioperative quality of life in patients under enhanced recovery after surgery care in colorectal cancer

DOI: 10.17235/reed.2020.6423/2019

Review

Vedolizumab for treatment of chronic refractory pouchitis: a systematic review with pool analysis

DOI: 10.17235/reed.2019.6336/2019

Original

Development and validation of the QUECOMIICAT questionnaire: a tool to assess disease-related knowledge in patients with inflammatory bowel disease

DOI: 10.17235/reed.2019.6298/2019

Case Report

Regression of a giant pseudopolyp in a patient with colonic Crohn’s disease after therapy with infliximab

DOI: 10.17235/reed.2019.6252/2019

Original

Differences in the need for adalimumab dose optimization between Crohn’s disease and ulcerative colitis

DOI: 10.17235/reed.2019.6148/2018

Original

Long-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents

DOI: 10.17235/reed.2019.6063/2018

Original

Quality of life and 3D-EUS assessment for anal incontinence after childbirth

DOI: 10.17235/reed.2019.6040/2018

Letter

A rare lymphoproliferative disorder associated with immunomodulating therapy in Crohn’s disease

DOI: 10.17235/reed.2019.5990/2018

Case Report

Leukocytoclastic vasculitis after vaccination in a patient with inflammatory bowel disease

DOI: 10.17235/reed.2019.5963/2018

Letter

The onset of ulcerative colitis during treatment with secukinumab: can anti-IL-17A be a trigger for inflammatory bowel disease?

DOI: 10.17235/reed.2019.5841/2018

Original

Survival and quality of life after surgery for colorectal cancer in the elderly: a comparative study

DOI: 10.17235/reed.2018.5807/2018

Letter

Intravenous ustekinumab reinduction as a Crohn’s disease rescue strategy following a secondary non-response

DOI: 10.17235/reed.2019.5802/2018

Original

Independent factors associated with the impact of gastroesophageal reflux disease on health-related quality of life

DOI: 10.17235/reed.2018.5752/2018

Letter

Crohn’s disease and cystic fibrosis: there is still a lot to learn

DOI: 10.17235/reed.2018.5725/2018

Original

Vitamin D deficiency in outpatients with inflammatory bowel disease: prevalence and association with clinical-biological activity

DOI: 10.17235/reed.2018.5714/2018

Original

Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn’s disease

DOI: 10.17235/reed.2018.5691/2018

Letter

Sweet syndrome after treatment with vedolizumab in a patient with Crohn’s disease

DOI: 10.17235/reed.2018.5603/2018

Original

The association between de novo inflammatory bowel disease and celiac disease

DOI: 10.17235/reed.2019.5535/2018

Original

Bile acid malabsorption in patients with chronic diarrhea and Crohn’s disease

DOI: 10.17235/reed.2018.5376/2017

Original

Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months

DOI: 10.17235/reed.2018.5368/2017

Editorial

Measuring health-related quality of life (HRQoL) in functional dyspepsia: is it really important?

DOI: 10.17235/reed.2017.5418/2017

Original

Using the internet to evaluate the opinion of patients with inflammatory bowel disease with regard to the available information

DOI: 10.17235/reed.2018.5331/2017

Review

Intestinal tuberculosis and Crohn’s disease: the importance and difficulty of a differential diagnosis

DOI: 10.17235/reed.2018.5184/2017

Original

Can we rely on inflammatory biomarkers for the diagnosis and monitoring Crohn’s disease activity?

DOI: 10.17235/reed.2017.5126/2017

Original

Enteral nutrition is associated with a decreased risk of surgical intervention in Crohn’s disease patients with spontaneous intra-abdominal abscess

DOI: 10.17235/reed.2017.5116/2017

Original

Capsule endoscopy with PillCamSB2 versus PillCamSB3: has the improvement in technology resulted in a step forward?

DOI: 10.17235/reed.2017.5071/2017

Case Report

Serrated polyposis syndrome associated with long-standing inflammatory bowel disease

DOI: 10.17235/reed.2017.5068/2017

Case Report

Efficacy and safety of vedolizumab as a treatment option for moderate to severe refractory ulcerative colitis in two patients after liver transplant due to primary sclerosing cholangitis

DOI: 10.17235/reed.2017.5024/2017

Letter to the Editor

Fecal transplantation as a treatment for Clostridium difficile infection in patients with ulcerative colitis

DOI: 10.17235/reed.2017.4941/2017

Original

Treatment persistence during therapeutic sequences with adalimumab and infliximab in the treatment of Crohn’s disease

DOI: 10.17235/reed.2017.4931/2017

Original

New psychometric data from the Spanish versions of the Glasgow Dyspepsia Severity Score and the Dyspepsia-Related Health Scale measures

DOI: 10.17235/reed.2017.4911/2017

Original

Medium to long-term efficacy and safety of oral tacrolimus in moderate to severe steroid refractory ulcerative colitis

DOI: 10.17235/reed.2017.4899/2017

Original

Knowledge of disease and access to a specialist reported by Spanish patients with ulcerative colitis. UC-LIFE survey

DOI: 10.17235/reed.2017.4748/2016

Letter to the Editor

Ulcerative colitis with gastric and duodenal involvement

DOI: 10.17235/reed.2017.4685/2016

Original

What is the real-life maintenance mesalazine dose in ulcerative colitis?

DOI: 10.17235/reed.2016.4620/2016

Editorial

Specialist care in the management of inflammatory bowel disease

DOI: 10.17235/reed.2016.4628/2016

Original

Mercaptopurine and inflammatory bowel disease: the other thiopurine

DOI: 10.17235/reed.2016.4546/2016

Original

Clinical status, quality of life, and work productivity in Crohn’s disease patients after one year of treatment with adalimumab

DOI: 10.17235/reed.2016.4600/2016

Original

Health-related quality of life in adults with irritable bowel syndrome in a Mexican specialist hospital. A cross-sectional study

DOI: 10.17235/reed.2017.4545/2016

Original

Coping with celiac disease: how heavy is the burden for caregivers?

DOI: 10.17235/reed.2017.4518/2016

Original

The use of a segmental endoscopic score may improve the prediction of clinical outcomes in acute severe ulcerative colitis

DOI: 10.17235/reed.2016.4470/2016

Original

Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn’s disease

DOI: 10.17235/reed.2016.4318/2016

Letter to the Editor

Adnexal localization of Crohn’s disease and recurrent massive ovary cysts

DOI: 10.17235/reed.2016.4301/2016

Original

Meta-analysis of the association between appendiceal orifice inflammation and appendectomy and ulcerative colitis

DOI: 10.17235/reed.2016.4176/2015

Digestive Diseases Image

All that glitters is not gold. A different cause for an "ulcerative colitis"

Original

Health-related quality of life and determinant factors in celiac disease. A population-based analysis of adult patients in Spain

DOI: 10.17235/reed.2016.4094/2015

Letter to the Editor

Ulcerative colitis in a patient with common variable immunodeficiency: does the treatment differ from the routine?

DOI: 10.17235/reed.2016.4115/2015

Original

Initial experience with golimumab in clinical practice for ulcerative colitis

DOI: 10.17235/reed.2016.4068/2015

Original

Endoluminal calprotectin measurement in assessment of pouchitis and a new index of disease activity: a pilot study

DOI: 10.17235/reed.2016.4066/2015

Case Report

Mesalamine-induced myopericarditis - A case report

DOI: 10.17235/reed.2016.4016/2015

Original

Predictive factors of small bowel patency in Crohn's disease patients

DOI: 10.17235/reed.2015.3957/2015

Case Report

Metastatic Crohn’s disease in pediatrics

DOI: 10.17235/reed.2016.3948/2015

Original

Using autologous platelet-rich plasma for the treatment of complex fistulas

DOI: 10.17235/reed.2016.3946/2015

Editorial

INTENSIFICATION OF MAINTENANCE THERAPY WITH INFLIXIMAB IN ULCERATIVE COLITIS

DOI: 10.17235/reed.2015.3907/2015

Letter to the Editor

Crohn’s disease and Sweet’s syndrome: A debut together

DOI: 10.17235/reed.2015.3842/2015

Original

Impact of endoscopic monitoring in postoperative Crohn’s disease patients already receiving pharmacological prevention of recurrence

DOI: 10.17235/reed.2015.3836/2015

Original

FREQUENCY, PREDICTORS, AND CONSEQUENCES OF MAINTENANCE INFLIXIMAB THERAPY INTENSIFICATION IN ULCERATIVE COLITIS

DOI: 10.17235/reed.2015.3804/2015

Case Report

Primary liposarcoma of the sigmoid presenting as colonic intussusception - A case report

DOI: 10.17235/reed.2016.3943/2015

Case Report

Ovarian involvement in Crohn´s disease: A rare complication

DOI: 10.17235/reed.2015.3764/2015

Original

Impact of the age of diagnosis on the natural history of ulcerative colitis

DOI: 10.17235/reed.2015.3736/2015

Citation tools
Berroa de la Rosa E, Mora Cuadrado N, Fernández Salazar L. The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire. 4621/2016


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1118 visits.
This article has been downloaded 145 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 14/09/2016

Accepted: 13/11/2016

Online First: 20/02/2017

Published: 28/02/2017

Article revision time: 54 days

Article Online First time: 159 days

Article editing time: 167 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Home
Articles
Current issues
Previous issues
Most read articles
Clinical guidelines
Reviews
Topic collection
Submit a manuscript
Submit a manuscript
Information for authors
Language editing services
Editorial time – Publication time
REED awards
ORCID guide
PubMed guide
Journal info
About the journal
Editorial board
For reviewers
For advertisers
REED centenary
Open access
Articles in press
Home
Articles
Current issues
Previous issues
Most read articles
Clinical guidelines
Reviews
Topic collection
Submit a manuscript
Submit a manuscript
Information for authors
Language editing services
Editorial time – Publication time
REED awards
ORCID guide
PubMed guide
Journal info
About the journal
Editorial board
For reviewers
For advertisers
REED centenary
Open access
Articles in press
Home
Articles
Current issues
Previous issues
Most read articles
Clinical guidelines
Reviews
Topic collection
Submit a manuscript
Submit a manuscript
Information for authors
Language editing services
Editorial time – Publication time
REED awards
ORCID guide
PubMed guide
Journal info
About the journal
Editorial board
For reviewers
For advertisers
REED centenary
Open access
Articles in press
Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology